Justera Health Ltd. (CSE:VTAL)
Canada
· Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
May 9, 2025, 4:00 PM EDT
Justera Health Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 1.42 | 1.91 | 14.69 | 19.59 | - | Upgrade
|
| Revenue Growth (YoY) | -25.79% | -86.97% | -25.01% | - | - | Upgrade
|
| Cost of Revenue | 0.54 | 1.06 | 12.11 | 17.1 | - | Upgrade
|
| Gross Profit | 0.88 | 0.86 | 2.58 | 2.49 | - | Upgrade
|
| Selling, General & Admin | 3.2 | 4.22 | 5.39 | 4.2 | 0.07 | Upgrade
|
| Operating Expenses | 3.34 | 4.69 | 6.5 | 6.04 | 0.07 | Upgrade
|
| Operating Income | -2.46 | -3.83 | -3.92 | -3.56 | -0.07 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.1 | 0.02 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -2.35 | -3.81 | -3.92 | -3.56 | -0.07 | Upgrade
|
| Impairment of Goodwill | - | -3.2 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.46 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.06 | 0.14 | - | - | - | Upgrade
|
| Asset Writedown | - | -1.02 | - | - | - | Upgrade
|
| Other Unusual Items | -1.46 | 4.87 | -1.33 | -5.82 | - | Upgrade
|
| Pretax Income | -4.21 | -3.02 | -5.25 | -9.38 | -0.07 | Upgrade
|
| Income Tax Expense | - | -0.04 | - | - | - | Upgrade
|
| Net Income | -4.21 | -2.98 | -5.25 | -9.38 | -0.07 | Upgrade
|
| Net Income to Common | -4.21 | -2.98 | -5.25 | -9.38 | -0.07 | Upgrade
|
| Shares Outstanding (Basic) | 179 | 128 | 87 | 33 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 179 | 128 | 87 | 33 | 5 | Upgrade
|
| Shares Change (YoY) | 39.49% | 47.04% | 167.06% | 567.07% | - | Upgrade
|
| EPS (Basic) | -0.02 | -0.02 | -0.06 | -0.29 | -0.01 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.02 | -0.06 | -0.29 | -0.01 | Upgrade
|
| Free Cash Flow | 0.41 | -1.05 | -1.19 | -1.2 | -0.02 | Upgrade
|
| Free Cash Flow Per Share | 0.00 | -0.01 | -0.01 | -0.04 | -0.00 | Upgrade
|
| Gross Margin | 62.11% | 44.75% | 17.56% | 12.70% | - | Upgrade
|
| Operating Margin | -172.93% | -200.03% | -26.67% | -18.15% | - | Upgrade
|
| Profit Margin | -296.58% | -155.71% | -35.74% | -47.85% | - | Upgrade
|
| Free Cash Flow Margin | 29.19% | -54.87% | -8.09% | -6.12% | - | Upgrade
|
| EBITDA | -2.32 | -3.54 | -3.42 | -3.24 | - | Upgrade
|
| EBITDA Margin | -163.31% | -185.11% | -23.28% | -16.56% | - | Upgrade
|
| D&A For EBITDA | 0.14 | 0.29 | 0.5 | 0.31 | - | Upgrade
|
| EBIT | -2.46 | -3.83 | -3.92 | -3.56 | -0.07 | Upgrade
|
| EBIT Margin | -172.93% | -200.03% | -26.67% | -18.15% | - | Upgrade
|
Updated Dec 2, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.